Dec 17, 2020

The National Hemophilia Foundation (NHF) is pleased to announce the appointment of three new board members, Paulette Charese Bryant, MD, FAAP; Maria Eileen V. San Juan, MSPT, and Kai Brown, MBA to help guide NHF in to a successful future.  

“We are excited to welcome to our board of directors three new members who will bring diverse insights and expertise to the work we do for the bleeding disorders community,” said Dr. Leonard Valentino, president and CEO of the NHF. “We are fortunate to have them join us as we continue to strengthen the community and move our mission forward.”

Paulette Charese Bryant, MD, FAAP lives in Charlotte, NC and is currently the medical director of hematology St. Jude Affiliate Clinic. Maria Eileen V. San Juan, MSPT resides in the New York area and is a physical therapist at Mount Sinai School of Medicine Hemophilia Treatment Center, Count On ME Therapy and Wellness Services, and Genesis Rehabilitation. Kai Brown, MBA resides in California and is a biotech executive in charge of new product planning at Myokardia, Inc.

“We were very pleased to have such a large pool of highly-qualified individuals for our members to choose from,” said Dr. Scott Miller, NHF board chair. “The board is looking forward to its continued professional growth and development as we continue to add individuals with highly sought-after skills that will enhance NHF’s mission and our journey toward our vision.”


About the National Hemophilia Foundation

NHF (the National Hemophilia Foundation) is a 501(c)(3) nonprofit organization dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research. NHF’s programs and initiatives are made possible through the generosity of individuals, corporations and foundations, as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC). Additional information on hemophilia and NHF can be found at